Metabolic Information and Courses from MediaLab, Inc.
These are the MediaLab courses that cover Metabolic and links to relevant pages within the course.
Learn more about laboratory continuing education for medical technologists to earn CE credit for AMT, ASCP, NCA, and state license renewal and recertification. Or get information about laboratory safety and compliance courses that deliver cost-effective OSHA safety training and continuing education to your laboratory's employees.
| pH Value Due to the wide range in urine pH values in healthy individuals, pH results must be evaluated in conjunction with the patient's medical condition. Factors to be considered include: respiratory or metabolic acidosis respiratory or metabolic alkalosis renal function crystal or calculi formation urinary tract status diet | View Page |
| Acid and alkaline urine pH Reasons for acidic urine pH include: a high-meat diet, respiratory/metabolic acidosis, and hypochloridemia. A urine with a high concentration of glucose may also have a lower pH. An alkaline pH may be the result of a vegetarian diet, respiratory/metabolic alkalosis, or a bacterial infection caused by urease-producing bacteria. Urine that contains bacteria can become more alkaline if the specimen remains at room temperature for an extended period of time. | View Page |
| Match the following factors with the expected pH: | View Page |
| Metabolic acidosis is characterized by: | View Page |
| What condition is indicated by the following blood gas results:
Bicarbonate = 32 mEq/L
pCO2 = 65 mm Hg
pH = 7.28 | View Page |
| Which of the following specimens would not be considered suitable for anaerobic culture: | View Page |
| Other Reducing Substances Although glucose is the sugar most commonly tested for in urine, normal human urine can contain small amounts of galactose, lactose, fructose, xylose, and other pentoses. Galactosuria, an abnormal amount of galactose in the urine, occurs in infants with a congenital metabolic defect. Lactose may be found in the urine of nursing women and during late pregnancy. All of these sugars, including glucose, are reducing substances. | View Page |
| Testing for Reducing Substances Other Than Glucose Testing pediatric urine specimens for reducing substances other than glucose is a policy that should be implemented in the urinalysis laboratory. The maximum age for this testing is defined by each laboratory and is usually based on consultation with the pediatric clinical staff. The policy that is implemented in most laboratories is to test urine specimens for other reducing substances if the glucose test on the reagent strip is negative and the urine specimen is from a child below the age of one. Verify the policy for your own laboratory because the cutoff age for testing may be different. | View Page |
| An Introduction to the Fundamentals of Coagulation As we will discover later in the course, there are other variables which impact the effectiveness of hemostatic mechanisms as well, such as acquired disease states, and inborn metabolic pathway defects.
For now, however, our focus will be on the mechanisms, processes, and components which work together to achieve coagulation, or the cessation of blood flow from a damaged vessel.
Note: The terms coagulation and hemostasis are used interchangeably throughout this course.
| View Page |
| Anticoagulation Therapy - Oral Anticoagulant Therapy The therapeutic use of oral anticoagulants is typically the long-term solution for the patient in terms of managing situations of thrombosis. Warfarin, a dicumarol derivative, is one of the most popular oral anticoagulants used today. While heparin is administered intravenously and acts to inhibit thrombin, warfarin is given orally, taken in pill form, and functions as a Vitamin K antagonist. In earlier discussions, it was mentioned that certain clotting factors are considered to be vitamin K dependant. They require vitamin K molecules for their action to occur. Vitamin K dependant factors include factor II, VII, IX, and X. Vitamin K dependant metabolic processes involved with these coagulation factors are inhibited by drugs such as warfarin. The chemical structure of warfarin and similar anticoagulants enables them to bind competitively with free vitamin K. The prothrombin time (PT/INR) is used to monitor oral anticoagulant therapy. | View Page |
| Match the names of each of the fungi listed below into the appropriate category indicating the classification of infection with which it is most commonly associated. | View Page |
| Metabolizers When discussing PGx, we classify a person according to his/her phenotype (metabolic capacity for a given enzyme).A poor metabolizer (PM) is a person who lacks the functional enzyme and therefore exhibits decreased metabolism of drugs. This person would require lower doses of a drug that is metabolized by that enzyme. A PM who receives a standard dose is more likely to experience unwanted side effects or toxicity. A PM can also experience diminished effects with drugs that need to be metabolized to active compounds by the enzyme in question.An ultrarapid metabolizer (UM) will require a higher dose than usual since he/she will eliminate the drug more quickly. A UM may be resistant to standard treatments, and it may take some time to adjust the dosage before therapy is achieved.An intermediate metabolizer (IM) has one wild-type (normal) copy of the gene and one absent or dysfunctional copy. The IM group is very heterogeneous.A person with normal enzyme activity is referred to as an extensive metabolizer (EM). This person should respond to standard dosages of a drug. Most people are EM's. This is the population in which most dosing regimens have been worked out in clinical trials. | View Page |
| CYP2D6 CYP2D6 has received the most attention: It is estimated that about 25% of common drugs are metabolized by CYP2D6. CYP2D6 accounts for only about 1% of all CYP450 enzymes, but it is important in the metabolism of about 100 drugs. There are more than 80 genetic variants that have been described in the CYP2D6 gene. The normal, wild-type allele displays normal metabolic activity whereas some of the variant forms have enhanced or diminished activity. The variants can be grouped generally according to the resulting alterations in protein function. The groupings correlate with four major enzyme metabolic capacities (phenotypes): poor, intermediate, extensive (normal), or ultra-rapid metabolizers. | View Page |
| Genotype versus Phenotype Phenotyping involves measuring the metabolism of a probe drug. For example, with CYP2D6, dextromethorphan or debrisoquine can be given to a patient to see how well the drug is metabolized. Both these drugs are safe and extensively metabolized by CYP2D6. By measuring the parent drug and the metabolite in urine, the metabolic capacity of a CYP450 enzyme can be estimated. Such testing is complex and tedious, however, and has not become routine in clinical laboratories. Therefore, genotyping is likely to be the main tool that is used for assessing the PGx of a patient. | View Page |
| Basic metabolic panel (BMP) Consists of an electrolyte panel, plus:
Blood urea nitrogen (BUN), which a measure of renal function.
Creatinine (Creat), which also measures renal function
Glucose, the most important blood sugar, and
Calcium.
Run on serum or plasma
| View Page |
| Comprehensive metabolic panel (CMP) Consists of a basic metabolic panel, plus:Albumin (Alb) and Bilirubin (Bili)
Alkaline Phosphatase (Alk Phos)
Total protein (TP)
Alanine aminotransferase (ALT)
Aspartate aminotransferase (AST)
| View Page |
| Panels or profiles These are some of the panels you will frequently encounter:
Hemogram (CBC)Electrolytes (Lytes)
Basic Metabolic Profile (BMP)Comprehensive Metabolic Profile (CMP) | View Page |
| Echinocytes Echinocyte comes from the Greek word meaning “sea urchin,” which relates to its shell-like appearance. Echinocytes are reversible, meaning that this alteration can be the result of the cell’s environment, pH of the medium (including the glass slides on which blood smears are made), the metabolic state of the cell and the use of some chemical substances. An example of an echinocyte can be seen in the center of this slide. Notice the projections (10-30 can be seen) are rounded and evenly spaced around the cell. Acanthocytes have irregularly spaced thorn-like projections. An echinocyte is shown left of the B in this photomicrograph. A polychromatophilic cell is seen just above the echinocyte. | View Page |
| Crystals Crystals are not usually present in freshly voided urine, but can appear in urine left at room temperature for several hours. Most crystals form due to changes in urine pH and temperature after collection. Diagnostically significant crystals may indicate the presence of a metabolic disorder, renal calculi formation, or provide information that can be used to regulate medications. | View Page |
| Review of Common Crystals The following table lists common crystals found in the urine sediment. Crystals that have no clinical significance must be identified and differentiated from those that can be an indication of a metabolic disorder or other clinically significant conditions. Crystal pH Color Uric Acid Acidic Yellow - Brown Calcium Oxalate Acidic/Neutral Colorless Amorphous Urates Acidic Yellow - Brown Triple Phosphate Alkaline Colorless Ammonium Biruate Alkaline Yellow - Brown Amorphous Phosphate Alkaline/Neutral White - Colorless Calcium Carbonate Alkaline Colorless | View Page |
| The granulated neutrophil shown in the photograph may be found in each of the following conditions except: | View Page |